Publications by authors named "I D Delgado-Mejia"
Article Synopsis
- The study aimed to investigate how often low scores occur on three neuropsychological tests assessing executive function in a large group of healthy children from Latin America and Spain.
- Findings revealed that low scores are more common than expected when looking at multiple outcomes, even in healthy individuals.
- Clinicians should be cautious about interpreting low scores as cognitive deficits, as these scores may be more frequent, potentially leading to incorrect diagnoses in children.
Objective: To generate normative data for the Concentration Endurance Test (d2) in Spanish-speaking pediatric populations.
Method: The sample consisted of 4,373 healthy children from nine countries in Latin America (Chile, Cuba, Ecuador, Guatemala, Honduras, Mexico, Paraguay, Peru, and Puerto Rico) and Spain. Each participant was administered the d2 test as part of a larger neuropsychological battery.
Objective: To generate normative data for the Stroop Word-Color Interference test in Spanish-speaking pediatric populations.
Method: The sample consisted of 4,373 healthy children from nine countries in Latin America (Chile, Cuba, Ecuador, Guatemala, Honduras, Mexico, Paraguay, Peru, and Puerto Rico) and Spain. Each participant was administered the Stroop Word-Color Interference test as part of a larger neuropsychological battery.
Objective: To generate normative data for the Modified Wisconsin Card Sorting Test (M-WCST) in Spanish-speaking pediatric populations.
Method: The sample consisted of 4,373 healthy children from nine countries in Latin America (Chile, Cuba, Ecuador, Guatemala, Honduras, Mexico, Paraguay, Peru, and Puerto Rico) and Spain. Each participant was administered the M-WCST as part of a larger neuropsychological battery.
Objective: To generate normative data for the Peabody Picture Vocabulary Test-III (PPVT-III) in Spanish-speaking pediatric populations.
Method: The sample consisted of 4,373 healthy children from nine countries in Latin America (Chile, Cuba, Ecuador, Honduras, Guatemala, Mexico, Paraguay, Peru, and Puerto Rico) and Spain. Each participant was administered the PPVT-III as part of a larger neuropsychological battery.